(Total Views: 169)
Posted On: 08/29/2020 8:34:31 PM
Post# of 124858
$KIN Breakout Friday, no news.
https://stockcharts.com/h-sc/ui?s=KIN&p=D...3586407613
Description
Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.
https://finance.yahoo.com/quote/KIN/profile?p=KIN
https://stockcharts.com/h-sc/ui?s=KIN&p=D...3586407613
Description
Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.
https://finance.yahoo.com/quote/KIN/profile?p=KIN
(0)
(0)Scroll down for more posts ▼
